Miller, K <br/><br/>
[Cardiovascular risks of androgen deprivation therapy for prostate cancer].  [electronic resource] 

 -  Der Urologe. Ausg. A  May 2016 
 - 627-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1433-0563 
<br/><br/><label>Standard No.: </label>10.1007/s00120-015-0021-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--adverse effects<br/>Cardiovascular Diseases--chemically induced<br/>Coronary Disease--chemically induced<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Male<br/>Myocardial Infarction--chemically induced<br/>Neoplasm Staging<br/>Orchiectomy<br/>Prostatic Neoplasms--drug therapy<br/>Risk Factors<br/>Stroke--chemically induced